IP Library Granted Patent US 12,473,588
Granted Patent B2
US 12,473,588 · App. 18/160,829 · Granted Nov 18, 2025

Chemical and thermal assisted nucleic acid amplification methods

Inventors: Allen Lipson (San Diego, CA); Daan Witters (San Diego, CA); Eli N. Glezer (Del Mar, CA)
Assignee: Singular Genomics Systems, Inc.
C12Q1/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,473,588
App. No.
18/160,829
Filed
Jan 27, 2023
Granted
Nov 18, 2025
Kind
B2
Art Unit
1681
USPC
435/6.12
Abstract

Disclosed herein, inter alia, are novel methods pertaining to nucleic acid amplification and detection. Devices, compositions, and kits for use in such methods are also provided.

Claims (36)

1 . A method of amplifying a template polynucleotide, said method comprising:

(a) annealing a template polynucleotide to a first immobilized primer on a solid support at a first temperature, wherein the first immobilized primer is complementary to a sequence of the template polynucleotide, wherein the first temperature is about 25° C. to about 45° C.;

(b) contacting the solid support with an extension solution and extending the first immobilized primer with a polymerase to generate a complement template polynucleotide, wherein contacting the solid support with an extension solution occurs at the first temperature and remains in contact with the solid support as the temperature is increased to a second temperature;

(c) contacting the solid support with a chemical denaturant and separating the complement template polynucleotide from the template polynucleotide, wherein:

i) contacting the solid support with a chemical denaturant occurs at the second temperature and remains in contact with the solid support as the temperature is decreased to the first temperature, and

ii) the second temperature is greater than the first temperature by 12° C. to 18° C.;

(d) removing the chemical denaturant and annealing the complement template polynucleotide to a second immobilized primer on said solid support at the first temperature, wherein the second immobilized primer is complementary to a sequence of the complement template polynucleotide, and;

(e) contacting the solid support with the extension solution and extending the second immobilized primer with the polymerase to generate an amplification product.

2 . The method of claim 1 , further comprising extending the first immobilized primer at the first temperature.

3 . The method of claim 1 , further comprising extending the first immobilized primer at the second temperature.

4 . The method of claim 1 , wherein step (c) comprises decreasing the second temperature to the first temperature occurs at a controlled rate.

5 . The method of claim 1 , wherein step (b) comprises increasing the first temperature to the second temperature at a controlled rate.

6 . The method of claim 1 , wherein the first temperature is about 40° C. to about 45° C.

7 . The method of claim 1 , wherein the second temperature is about 55° C. to about 62° C.

8 . The method of claim 1 , further comprising prior to step (a) contacting the solid support with a sample comprising a template polynucleotide.

9 . The method of claim 1 , further comprising repeating steps (a) to (e), thereby amplifying the template polynucleotide.

10 . The method of claim 1 , wherein the chemical denaturant comprises formamide, ethylene glycol, or sodium hydroxide.

11 . The method of claim 1 , wherein removing the chemical denaturant comprises application of a wash solution.

12 . The method of claim 1 , wherein the first temperature is about 40° C. and the second temperature is about 58° C.

13 . The method of claim 1 , in step (b), the solid support remains in contact with the extension solution for 45 seconds at the second temperature, where the second temperature is 58° C.

14 . The method of claim 1 , in step (c), the solid support remains in contact with the chemical denaturant for 45 seconds as the temperature reduces to the first temperature, where the first temperature is 42° C.

15 . The method of claim 1 , in step (c), the solid support remains in contact with the chemical denaturant for 5-15 seconds at the second temperature prior to decreasing to the first temperature.

16 . A method of amplifying a template polynucleotide, said method comprising:

(a) annealing a template polynucleotide to a first immobilized primer on a solid support at a first temperature, wherein the first immobilized primer is complementary to a sequence of the template polynucleotide, wherein the first temperature is about 35° C. to about 45° C.;

(b) contacting the solid support with an extension solution and extending the first immobilized primer to generate a complement template polynucleotide, wherein contacting the solid support with an extension solution occurs at the first temperature and remains in contact with the solid support as the temperature is increased to a second temperature;

(c) contacting the solid support with a chemical denaturant and separating the complement template polynucleotide from the template polynucleotide, wherein:

i) contacting the solid support with a chemical denaturant occurs at the second temperature and remains in contact with the solid support as the temperature is decreased to the first temperature, and

ii) the second temperature is 12° C. to 18° C. greater than the first temperature;

(d) removing the chemical denaturant and annealing a complement template polynucleotide to a second immobilized primer on said solid support at the first temperature, wherein the second immobilized primer is complementary to a sequence of the complement template polynucleotide;

(e) contacting the solid support with the extension solution and extending the second immobilized primer with the polymerase to generate an amplification product.

17 . The method of claim 16 , wherein the first temperature and the second temperature differ by about 15° C.

18 . The method of claim 16 , wherein the first temperature is about 40° C. to about 45° C.

19 . The method of claim 16 , wherein the second temperature is about 55° C. to about 62° C.

20 . The method of claim 16 , in step (b), the solid support remains in contact with the extension solution for 45 seconds at the second temperature, wherein the second temperature is 58° C.

21 . The method of claim 16 , in step (c), the solid support remains in contact with the chemical denaturant for 45 seconds as the temperature reduces to the first temperature, where the first temperature is 42° C.

22 . The method of claim 16 , in step (c), the solid support remains in contact with the chemical denaturant for 5-15 seconds at the second temperature prior to decreasing to the first temperature.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2023
From: LIPSON, ALLEN; WITTERS, DAAN; GLEZER, ELI N.
To: SINGULAR GENOMICS SYSTEMS, INC
Reel/Frame 062722/0498 →
Continuity (4)
Continuation PCTUS2022075197 · Aug 19, 2022
Provisional Application 63301214 · Jan 20, 2022
Provisional Application 63235667 · Aug 20, 2021
Related Publication 20230175049A1 · Jun 8, 2023
References Cited (75)
US 4318846A · Khanna et al. · 1982 [cited by applicant]
US 5034506A · Summerton et al. · 1991 [cited by applicant]
US 5066580A · Lee · 1991 [cited by applicant]
US 5235033A · Summerton et al. · 1993 [cited by applicant]
US 5366860A · Bergot et al. · 1994 [cited by applicant]
US 5554516A · Kacian et al. · 1996 [cited by applicant]
US 5599675A · Brenner · 1997 [cited by applicant]
US 5641658A · Adams et al. · 1997 [cited by applicant]
US 5688648A · Mathies et al. · 1997 [cited by applicant]
US 5750341A · Macevicz · 1998 [cited by applicant]
US 5763594A · Hiatt et al. · 1998 [cited by applicant]
US 5800996A · Lee et al. · 1998 [cited by applicant]
US 5808045A · Hiatt et al. · 1998 [cited by applicant]
US 5847162A · Lee et al. · 1998 [cited by applicant]
US 5872244A · Hiatt et al. · 1999 [cited by applicant]
US 6031091A · Arnold et al. · 2000 [cited by applicant]
US 6210891B1 · Nyren et al. · 2001 [cited by applicant]
US 6232465B1 · Hiatt et al. · 2001 [cited by applicant]
US 6258568B1 · Nyren · 2001 [cited by applicant]
US 6274320B1 · Rothberg et al. · 2001 [cited by applicant]
US 6664079B2 · Ju et al. · 2003 [cited by applicant]
US 7057026B2 · Barnes et al. · 2006 [cited by applicant]
US 7115400B1 · Adessi et al. · 2006 [cited by applicant]
US 7541444B2 · Milton et al. · 2009 [cited by applicant]
US 8178360B2 · Barnes et al. · 2012 [cited by applicant]
US 9334531B2 · Li et al. · 2016 [cited by applicant]
US 10738072B1 · Graham et al. · 2020 [cited by applicant]
US 11236387B2 · Glezer et al. · 2022 [cited by applicant]
US 20070218490A1 · Laikhter et al. · 2007 [cited by applicant]
US 20080000373A1 · Petrucci-Samija et al. · 2008 [cited by applicant]
US 20080009420A1 · Schroth et al. · 2008 [cited by applicant]
US 20100160478A1 · Nilsson et al. · 2010 [cited by applicant]
US 20100167353A1 · Walder et al. · 2010 [cited by applicant]
US 20110059865A1 · Smith et al. · 2011 [cited by applicant]
US 20130012399A1 · Myers et al. · 2013 [cited by applicant]
US 20140080717A1 · Li · 2014 [cited by examiner]
US 20150079351A1 · Atasoy et al. · 2015 [cited by applicant]
US 20160256846A1 · Smith et al. · 2016 [cited by applicant]
US 20160362725A1 · Cai et al. · 2016 [cited by applicant]
US 20170022553A1 · Vijayan et al. · 2017 [cited by applicant]
US 20180258472A1 · Glezer · 2018 [cited by applicant]
US 20180274024A1 · Ju et al. · 2018 [cited by applicant]
US 20190048404A1 · Dambacher · 2019 [cited by applicant]
US 20200316606A1 · Soto-Moreno · 2020 [cited by examiner]
US 20210190668A1 · Kovacs et al. · 2021 [cited by applicant]
WO WO1989010977A1 · 1989 [cited by applicant]
WO WO1996007669A1 · 1996 [cited by applicant]
WO WO2004018497A2 · 2004 [cited by applicant]
WO WO2013028643A1 · 2013 [cited by applicant]
WO WO2017205336A1 · 2017 [cited by applicant]
WO WO2018148723A1 · 2018 [cited by applicant]
WO WO2020056044A1 · 2020 [cited by applicant]
WO WO2022165188A1 · 2022 [cited by examiner]
Wang, Characterization of denaturation and renaturation of DNA for DNA hybridization, Environ Health Toxicol, 29: e2014007, 2014. (Year: 2014). [cited by examiner]
Bains, W. et al. (Dec. 7, 1988). “A novel method for nucleic acid sequence determination,” [cited by applicant]
Bentley, D. R. et al. (Nov. 6, 2008). “Accurate whole human genome sequencing using reversible terminator chemistry,” [cited by applicant]
Bergen, K. et al. (Jun. 17, 2013, e-published Jun. 3, 2013). “Structures of KOD and 9° N DNA polymerases complexed with primer template duplex,” [cited by applicant]
Drmanac, S. et al. (Jan. 1998). “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,” [cited by applicant]
Findlay, J. B. et al. (Sep. 1, 1993). “Automated closed-vessel system for in vitro diagnostics based on polymerase chain reaction,” [cited by applicant]
Fodor, S. P. et al. (Feb. 15, 1991). “Light-directed, spatially addressable parallel chemical synthesis,” [cited by applicant]
Fuller, C. W. et al. (May 10, 2016, e-published Apr. 18, 2016). “Real-time single-molecule electronic DNA sequencing by synthesis using polymer-tagged nucleotides on a nanopore array,” [cited by applicant]
Guo, J. et al. (Jul. 8, 2008, e-published Jun. 30, 2008). “Four-color DNA sequencing with 3′-O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides,” [cited by applicant]
Haas, E. et al. (Jan. 15, 1975). “Distribution of end-to-end distances of oligopeptides in solution as estimated by energy transfer,” [cited by applicant]
International Search Report mailed on Nov. 4, 2022, for PCT Application No. PCT/US2022/75197, filed Aug. 19, 2022, 2 pages. [cited by applicant]
Kumar, S. et al. (2012, e-published Sep. 21, 2012). “PEG-labeled nucleotides and nanopore detection for single molecule DNA sequencing by synthesis,” [cited by applicant]
Mag, M. et al. (Nov. 24, 1992, e-published Mar. 5, 2001). “Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged non-chiral internucleotide 3′-phosphoramidate linkage,” [cited by applicant]
Ronaghi, M. et al. (Nov. 1, 1996, e-published May 25, 2002). “Real-time DNA sequencing using detection of pyrophosphate release,” [cited by applicant]
Ronaghi, M. et al. (Jul. 17, 1998). “A sequencing method based on real-time pyrophosphate,” [cited by applicant]
Ronaghi, M. (Jan. 2001). “Pyrosequencing sheds light on DNA sequencing,” [cited by applicant]
Shendure, J. et al. (Sep. 9, 2005, e-published Aug. 4, 2005). “Accurate multiplex polony sequencing of an evolved bacterial genome,” [cited by applicant]
Southworth, M. W. et al. (May 28, 1996). “Cloning of thermostable DNA polymerases from hyperthermophilic marine Archaea with emphasis on [cited by applicant]
Walker, J. W., et al. (Oct. 1, 1998, e-published May 1, 2002). “Photolabile 1-(2-nitrophenyl) ethyl phosphate esters of adenine nucleotide analogs. Synthesis and mechanism of photolysis,” [cited by applicant]
Wilding, P.et al. (Sep. 1, 1994). “PCR in a silicon microstructure,” [cited by applicant]
Wilk, A. et al. (Apr. 25, 1990). “Backbone-modified oligonucleotides containing a butanediol-1, 3 moiety as a ‘vicarious segment’ for the deoxyribosyl moiety—synthesis and enzyme studies,” [cited by applicant]
Written Opinion mailed on Nov. 4, 2022, for PCT Application No. PCT/US2022/75197, filed Aug. 19, 2022, 7 pages. [cited by applicant]